The Novel HLA ‐A*68 Allele, HLA ‐A*68:02:27, Identified by Next Generation Sequencing
HLA · 2025
DOI: 10.1111/tan.70226 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2025. Verfasst von Bobbie Rhodes-Clark und 1 weiteren Autor:innen. Beteiligte Einrichtung: Vitalant HLA Laboratory, Mather, California, USA. Hauptthemen laut MEDLINE: Alleles, High-Throughput Nucleotide Sequencing, Exons, HLA-A Antigens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
HLA‐A*68:02:27 differs from HLA‐A‐68:02:01:01 by a single nucleotide variation in Exon 4, codon 206.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Vitalant HLA Laboratory, Mather, California, USA.
- University of Texas Health Science Center, Houston, Texas, USA.
ORCID-Profile: Bobbie Rhodes-Clark
Zitieren
APA
Rhodes-Clark, B., & Redding, C. (2025). The Novel HLA ‐A*68 Allele, HLA ‐A*68:02:27, Identified by Next Generation Sequencing. HLA. https://doi.org/10.1111/tan.70226
Vancouver
Rhodes-Clark B, Redding C. The Novel HLA ‐A*68 Allele, HLA ‐A*68:02:27, Identified by Next Generation Sequencing. HLA. 2025. doi:10.1111/tan.70226
BibTeX
@article{RhodesClark2025,
author = {Rhodes-Clark, Bobbie and Redding, Christine},
title = {The Novel HLA ‐A*68 Allele, HLA ‐A*68:02:27, Identified by Next Generation Sequencing},
journal = {HLA},
year = {2025},
doi = {10.1111/tan.70226}
}
EUVIMED